Načítá se...
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
Glioblastoma (GBM) is a challenging diagnosis with almost universally poor prognosis. Though the survival advantage of postoperative radiation (RT) is well established, around 90% of patients will fail in the RT field. The high likelihood of local failure suggests the efficacy of RT needs to be impr...
Uloženo v:
| Vydáno v: | Neurooncol Pract |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274183/ https://ncbi.nlm.nih.gov/pubmed/32537176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz057 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|